Neuropathic Pain
📧 Sign up to get email alerts when something new happens for Neuropathic Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis [Phase 3]
Phase 3 clinical trial evaluating long-term efficacy and tolerability of AP707 for chronic pain due to central neuropathy of various etiolog…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis [Phase 3]
Phase 3 clinical trial evaluating AP707 for chronic pain due to central neuropathy; efficacy and tolerability data are not yet fully disclos…
-
FDA approval · 2024-01-17FDA Approved: GABAPENTIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for gabapentin, a generic version of the anticonvulsant used for partial seizures …
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: The SNAP Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain [NA]
Clinical trial update for SNAP Trial investigating SPRINT peripheral nerve stimulation for neuropathic post-amputation pain; trial is termin…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain [Phase 2]
Phase 2 trial updates safety and efficacy of BAY2395840 in diabetic neuropathic pain due to diabetic peripheral neuropathy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy [Phase 2]
Phase 2 trial investigating nicotine for pain associated with chemotherapy-induced peripheral neuropathy was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain [Phase 4]
Phase 4 randomized study comparing pregabalin sustained release vs immediate release in type 2 diabetes patients with peripheral neuropathic…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain [Phase 2]
Phase 2 clinical trial investigating intrathecal oxytocin for neuropathic pain was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Spinal Cord Stimulation for Restless Legs Syndrome [NA]
A completed clinical trial investigated spinal cord stimulation as a treatment for Restless Legs Syndrome, with results posted in 2023.
-
FDA approval · 2023-08-07FDA Approved: GABAPENTIN — Supplemental Application (Ajenat Pharmaceuticals LLC)
FDA approves a supplemental application for Gabapentin submitted by Ajenat Pharmaceuticals LLC.
-
FDA approval · 2023-08-02FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for Gabapentin submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Efficacy and Safety of Pregabalin/Tramadol Combination Versus Pregabalin in Acute Pain of Neuropathic Origin [Phase 3]
Phase 3 trial comparing pregabalin/tramadol combination to pregabalin alone for acute neuropathic pain; completed study.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Flecainide in Treating Patients With Chronic Neuropathic Pain [Phase 2]
Phase 2 clinical trial evaluating flecainide for chronic neuropathic pain has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain [NA]
A completed clinical trial evaluating brain stimulation as a treatment for chronic pain, with results posted in 2023.
-
FDA approval · 2023-05-01FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's original application for Amitriptyline Hydrochloride (generic) under ANDA, authorizing its marketing in th…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Efficacy of an Intraoperative Periradicular Application of Platelet Rich Fibrin (PRF) on the Intensity of Residual Post-surgical Neuropathic Pain After a Surgery for Disc Herniation [Phase 3]
A Phase 3 trial evaluating intraoperative use of platelet rich fibrin to reduce residual neuropathic pain after disc herniation surgery; cur…
-
FDA approval · 2023-03-24FDA Approved: PREGABALIN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for pregabalin from Solco Healthcare US, LLC under ANDA207883. The drug is indicated for neuropathic…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer [Phase 2]
Phase 2 trial evaluating intrathecal ziconotide for neuropathic and cancer-related pain.
-
EMA withdrawal · 2023-03-20EMA Withdrawn: Pregabalin Zentiva k.s. (pregabalin) — Zentiva k.s.
The EMA withdrew pregabalin Zentiva k.s. from the market (Zentiva k.s.) with the therapeutic areas including anxiety disorders, neuralgia, a…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies [Phase 3]
Phase 3 trial comparing methadone to placebo for neuropathic pain across various etiologies has completed.
-
CLINICAL_TRIALS research · 2023-01-12Clinical Trial Update: Intraoperative Neuromonitoring Recording With a Novel SCS Paddle [NA]
A completed clinical trial studying intraoperative neuromonitoring recording with a novel spinal cord stimulator paddle for chronic and neur…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of NFX88 in neuropathic pain associated with spinal cord injuries has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis [NA]
A terminated clinical trial evaluating transcranial direct current stimulation for reducing neuropathic pain in people with multiple scleros…
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain [NA]
Completed clinical trial evaluating capsaicin 8% patch for spinal cord injury–related neuropathic pain; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Neuropathic Pain After Orchidectomy and Sex Reassignment Surgery
A completed clinical trial evaluating neuropathic and phantom pain after orchidectomy and sex reassignment surgery; results posted in 2022.